Cargando…
[Corrigendum] Hsp90 inhibitor 17‑AAG inhibits stem cell‑like properties and chemoresistance in osteosarcoma cells via the Hedgehog signaling pathway
Autores principales: | Shu, Xiong, Liu, Huiqi, Zhen, Rui, Jie, Yongsheng, Chen, Lei, Qi, Hui, Wang, Chao, Wang, Renxian, Chen, Dafu, Ran, Yuliang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10347100/ https://www.ncbi.nlm.nih.gov/pubmed/37350398 http://dx.doi.org/10.3892/or.2023.8593 |
Ejemplares similares
-
Repercussion of Mitochondria Deformity Induced by Anti-Hsp90 Drug 17AAG in Human Tumor Cells
por: Vishal, Chaturvedi, et al.
Publicado: (2011) -
A Novel Mechanism of 17-AAG Therapeutic Efficacy on HSP90 Inhibition in MYCN-Amplified Neuroblastoma Cells
por: Hanna, Reine, et al.
Publicado: (2021) -
HSP90 inhibitor 17AAG attenuates sevoflurane-induced neurotoxicity in rats and human neuroglioma cells via induction of HSP70
por: Liu, Min, et al.
Publicado: (2020) -
HSP90 Inhibitor 17-AAG Attenuates Nucleus Pulposus Inflammation and Catabolism Induced by M1-Polarized Macrophages
por: Zhang, Shuo, et al.
Publicado: (2022) -
17AAG Treatment Accelerates Doxorubicin Induced Cellular Senescence: Hsp90 Interferes with Enforced Senescence of Tumor Cells
por: Sarangi, Upasana, et al.
Publicado: (2012)